Cargando…
Differential Interactome Proposes Subtype-Specific Biomarkers and Potential Therapeutics in Renal Cell Carcinomas
Although many studies have been conducted on single gene therapies in cancer patients, the reality is that tumor arises from different coordinating protein groups. Unveiling perturbations in protein interactome related to the tumor formation may contribute to the development of effective diagnosis,...
Autores principales: | Caliskan, Aysegul, Gulfidan, Gizem, Sinha, Raghu, Arga, Kazim Yalcin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7926666/ https://www.ncbi.nlm.nih.gov/pubmed/33672271 http://dx.doi.org/10.3390/jpm11020158 |
Ejemplares similares
-
Current State of “Omics” Biomarkers in Pancreatic Cancer
por: Turanli, Beste, et al.
Publicado: (2021) -
Pan-cancer mapping of differential protein-protein interactions
por: Gulfidan, Gizem, et al.
Publicado: (2020) -
Differential Interactome Based Drug Repositioning Unraveled Abacavir, Exemestane, Nortriptyline Hydrochloride, and Tolcapone as Potential Therapeutics for Colorectal Cancers
por: Beklen, Hande, et al.
Publicado: (2021) -
Transcriptomic profile of Pea3 family members reveal regulatory codes for axon outgrowth and neuronal connection specificity
por: Kandemir, Başak, et al.
Publicado: (2020) -
Drug Repositioning for P-Glycoprotein Mediated Co-Expression Networks in Colorectal Cancer
por: Beklen, Hande, et al.
Publicado: (2020)